Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo ‐controlled crossover study

Movement Disorders, EarlyView.

Source: Movement Disorders - September 7, 2018 Category: Neurology Authors: Donald L. Gilbert MD , Tanya K. Murphy , Joseph Jankovic MD , Cathy L. Budman MD , Kevin J. Black MD , Roger M. Kurlan MD , Keith A. Coffman MD , James T. McCracken MD , Jorge Juncos MD , Jon E. Grant MD , Richard Source Type: research